VEGF-A Inhibition as a Potential Therapeutic Approach in Merkel Cell Carcinoma
Gespeichert in:
| Veröffentlicht in: | Journal of investigative dermatology 2019-03, Vol.139 (3), p.736-739 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 739 |
|---|---|
| container_issue | 3 |
| container_start_page | 736 |
| container_title | Journal of investigative dermatology |
| container_volume | 139 |
| creator | Kervarrec, Thibault Gaboriaud, Pauline Tallet, Anne Leblond, Valérie Arnold, Francoise Berthon, Patricia Schweinitzer, Sophie Larcher, Thibaut Guyétant, Serge Schrama, David Houben, Roland Samimi, Mahtab Touzé, Antoine |
| description | |
| doi_str_mv | 10.1016/j.jid.2018.08.029 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02621891v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022202X18326824</els_id><sourcerecordid>2126904708</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-8313dd353115f863a8204fcd7f0f8c63c32670f07dc8c23550084a7d383fed1c3</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMotlZ_gBfJUQ9bJ8l-ZPFUirWF-nFQ8RZiMktTt7s12Qr-e1OqPQpDAsPzvgwPIecMhgxYfr0cLp0dcmByCHF4eUD6LOMiYUVaHJI-AOcJB_7WIychLCFm0kwek54AkZVZkffJw-vt3SQZ0VmzcO-uc21DdaCaPrUdNp3TNX1eoNdr3HTO0NF67VttFtQ19B79B9Z0jHV8tDeuaVf6lBxVug549vsPyMvk9nk8TeaPd7PxaJ6YVECXSMGEtSITjGWVzIWWHNLK2KKCSppcGMHzAioorJGGiywDkKkurJCiQsuMGJCrXe9C12rt3Ur7b9Vqp6ajudrugOecyZJ9sche7th4--cGQ6dWLph4tm6w3QTFGc9LSAuQEWU71Pg2BI_VvpuB2ipXSxWVq61yBXF4GTMXv_Wb9xXafeLPcQRudgBGIV8OvQrGYWPQOo-mU7Z1_9T_ACxWjkQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2126904708</pqid></control><display><type>article</type><title>VEGF-A Inhibition as a Potential Therapeutic Approach in Merkel Cell Carcinoma</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Kervarrec, Thibault ; Gaboriaud, Pauline ; Tallet, Anne ; Leblond, Valérie ; Arnold, Francoise ; Berthon, Patricia ; Schweinitzer, Sophie ; Larcher, Thibaut ; Guyétant, Serge ; Schrama, David ; Houben, Roland ; Samimi, Mahtab ; Touzé, Antoine</creator><creatorcontrib>Kervarrec, Thibault ; Gaboriaud, Pauline ; Tallet, Anne ; Leblond, Valérie ; Arnold, Francoise ; Berthon, Patricia ; Schweinitzer, Sophie ; Larcher, Thibaut ; Guyétant, Serge ; Schrama, David ; Houben, Roland ; Samimi, Mahtab ; Touzé, Antoine</creatorcontrib><identifier>ISSN: 0022-202X</identifier><identifier>EISSN: 1523-1747</identifier><identifier>DOI: 10.1016/j.jid.2018.08.029</identifier><identifier>PMID: 30359576</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Antibodies, Monoclonal - therapeutic use ; Antineoplastic Agents - therapeutic use ; Cancer ; Carcinoma, Merkel Cell - drug therapy ; Female ; Humans ; Immunohistochemistry ; Immunotherapy - trends ; Life Sciences ; Mice ; Mice, Inbred NOD ; Neoplasm Staging ; Skin Neoplasms - drug therapy ; Tissue Array Analysis ; Tumor Microenvironment ; Vascular Endothelial Growth Factor A - antagonists & inhibitors ; Vascular Endothelial Growth Factor A - genetics ; Vascular Endothelial Growth Factor A - metabolism</subject><ispartof>Journal of investigative dermatology, 2019-03, Vol.139 (3), p.736-739</ispartof><rights>2018 The Authors</rights><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-8313dd353115f863a8204fcd7f0f8c63c32670f07dc8c23550084a7d383fed1c3</citedby><cites>FETCH-LOGICAL-c430t-8313dd353115f863a8204fcd7f0f8c63c32670f07dc8c23550084a7d383fed1c3</cites><orcidid>0000-0002-0396-3190 ; 0000-0002-2201-6914 ; 0000-0001-6742-9088 ; 0000-0002-3491-7613 ; 0000-0003-2783-9722 ; 0000-0002-9856-9945 ; 0000-0002-6931-8194</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30359576$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.inrae.fr/hal-02621891$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Kervarrec, Thibault</creatorcontrib><creatorcontrib>Gaboriaud, Pauline</creatorcontrib><creatorcontrib>Tallet, Anne</creatorcontrib><creatorcontrib>Leblond, Valérie</creatorcontrib><creatorcontrib>Arnold, Francoise</creatorcontrib><creatorcontrib>Berthon, Patricia</creatorcontrib><creatorcontrib>Schweinitzer, Sophie</creatorcontrib><creatorcontrib>Larcher, Thibaut</creatorcontrib><creatorcontrib>Guyétant, Serge</creatorcontrib><creatorcontrib>Schrama, David</creatorcontrib><creatorcontrib>Houben, Roland</creatorcontrib><creatorcontrib>Samimi, Mahtab</creatorcontrib><creatorcontrib>Touzé, Antoine</creatorcontrib><title>VEGF-A Inhibition as a Potential Therapeutic Approach in Merkel Cell Carcinoma</title><title>Journal of investigative dermatology</title><addtitle>J Invest Dermatol</addtitle><subject>Animals</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Cancer</subject><subject>Carcinoma, Merkel Cell - drug therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Immunotherapy - trends</subject><subject>Life Sciences</subject><subject>Mice</subject><subject>Mice, Inbred NOD</subject><subject>Neoplasm Staging</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Tissue Array Analysis</subject><subject>Tumor Microenvironment</subject><subject>Vascular Endothelial Growth Factor A - antagonists & inhibitors</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><subject>Vascular Endothelial Growth Factor A - metabolism</subject><issn>0022-202X</issn><issn>1523-1747</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMotlZ_gBfJUQ9bJ8l-ZPFUirWF-nFQ8RZiMktTt7s12Qr-e1OqPQpDAsPzvgwPIecMhgxYfr0cLp0dcmByCHF4eUD6LOMiYUVaHJI-AOcJB_7WIychLCFm0kwek54AkZVZkffJw-vt3SQZ0VmzcO-uc21DdaCaPrUdNp3TNX1eoNdr3HTO0NF67VttFtQ19B79B9Z0jHV8tDeuaVf6lBxVug549vsPyMvk9nk8TeaPd7PxaJ6YVECXSMGEtSITjGWVzIWWHNLK2KKCSppcGMHzAioorJGGiywDkKkurJCiQsuMGJCrXe9C12rt3Ur7b9Vqp6ajudrugOecyZJ9sche7th4--cGQ6dWLph4tm6w3QTFGc9LSAuQEWU71Pg2BI_VvpuB2ipXSxWVq61yBXF4GTMXv_Wb9xXafeLPcQRudgBGIV8OvQrGYWPQOo-mU7Z1_9T_ACxWjkQ</recordid><startdate>20190301</startdate><enddate>20190301</enddate><creator>Kervarrec, Thibault</creator><creator>Gaboriaud, Pauline</creator><creator>Tallet, Anne</creator><creator>Leblond, Valérie</creator><creator>Arnold, Francoise</creator><creator>Berthon, Patricia</creator><creator>Schweinitzer, Sophie</creator><creator>Larcher, Thibaut</creator><creator>Guyétant, Serge</creator><creator>Schrama, David</creator><creator>Houben, Roland</creator><creator>Samimi, Mahtab</creator><creator>Touzé, Antoine</creator><general>Elsevier Inc</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0002-0396-3190</orcidid><orcidid>https://orcid.org/0000-0002-2201-6914</orcidid><orcidid>https://orcid.org/0000-0001-6742-9088</orcidid><orcidid>https://orcid.org/0000-0002-3491-7613</orcidid><orcidid>https://orcid.org/0000-0003-2783-9722</orcidid><orcidid>https://orcid.org/0000-0002-9856-9945</orcidid><orcidid>https://orcid.org/0000-0002-6931-8194</orcidid></search><sort><creationdate>20190301</creationdate><title>VEGF-A Inhibition as a Potential Therapeutic Approach in Merkel Cell Carcinoma</title><author>Kervarrec, Thibault ; Gaboriaud, Pauline ; Tallet, Anne ; Leblond, Valérie ; Arnold, Francoise ; Berthon, Patricia ; Schweinitzer, Sophie ; Larcher, Thibaut ; Guyétant, Serge ; Schrama, David ; Houben, Roland ; Samimi, Mahtab ; Touzé, Antoine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-8313dd353115f863a8204fcd7f0f8c63c32670f07dc8c23550084a7d383fed1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Cancer</topic><topic>Carcinoma, Merkel Cell - drug therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Immunotherapy - trends</topic><topic>Life Sciences</topic><topic>Mice</topic><topic>Mice, Inbred NOD</topic><topic>Neoplasm Staging</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Tissue Array Analysis</topic><topic>Tumor Microenvironment</topic><topic>Vascular Endothelial Growth Factor A - antagonists & inhibitors</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><topic>Vascular Endothelial Growth Factor A - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kervarrec, Thibault</creatorcontrib><creatorcontrib>Gaboriaud, Pauline</creatorcontrib><creatorcontrib>Tallet, Anne</creatorcontrib><creatorcontrib>Leblond, Valérie</creatorcontrib><creatorcontrib>Arnold, Francoise</creatorcontrib><creatorcontrib>Berthon, Patricia</creatorcontrib><creatorcontrib>Schweinitzer, Sophie</creatorcontrib><creatorcontrib>Larcher, Thibaut</creatorcontrib><creatorcontrib>Guyétant, Serge</creatorcontrib><creatorcontrib>Schrama, David</creatorcontrib><creatorcontrib>Houben, Roland</creatorcontrib><creatorcontrib>Samimi, Mahtab</creatorcontrib><creatorcontrib>Touzé, Antoine</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Journal of investigative dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kervarrec, Thibault</au><au>Gaboriaud, Pauline</au><au>Tallet, Anne</au><au>Leblond, Valérie</au><au>Arnold, Francoise</au><au>Berthon, Patricia</au><au>Schweinitzer, Sophie</au><au>Larcher, Thibaut</au><au>Guyétant, Serge</au><au>Schrama, David</au><au>Houben, Roland</au><au>Samimi, Mahtab</au><au>Touzé, Antoine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>VEGF-A Inhibition as a Potential Therapeutic Approach in Merkel Cell Carcinoma</atitle><jtitle>Journal of investigative dermatology</jtitle><addtitle>J Invest Dermatol</addtitle><date>2019-03-01</date><risdate>2019</risdate><volume>139</volume><issue>3</issue><spage>736</spage><epage>739</epage><pages>736-739</pages><issn>0022-202X</issn><eissn>1523-1747</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>30359576</pmid><doi>10.1016/j.jid.2018.08.029</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-0396-3190</orcidid><orcidid>https://orcid.org/0000-0002-2201-6914</orcidid><orcidid>https://orcid.org/0000-0001-6742-9088</orcidid><orcidid>https://orcid.org/0000-0002-3491-7613</orcidid><orcidid>https://orcid.org/0000-0003-2783-9722</orcidid><orcidid>https://orcid.org/0000-0002-9856-9945</orcidid><orcidid>https://orcid.org/0000-0002-6931-8194</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-202X |
| ispartof | Journal of investigative dermatology, 2019-03, Vol.139 (3), p.736-739 |
| issn | 0022-202X 1523-1747 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_02621891v1 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Animals Antibodies, Monoclonal - therapeutic use Antineoplastic Agents - therapeutic use Cancer Carcinoma, Merkel Cell - drug therapy Female Humans Immunohistochemistry Immunotherapy - trends Life Sciences Mice Mice, Inbred NOD Neoplasm Staging Skin Neoplasms - drug therapy Tissue Array Analysis Tumor Microenvironment Vascular Endothelial Growth Factor A - antagonists & inhibitors Vascular Endothelial Growth Factor A - genetics Vascular Endothelial Growth Factor A - metabolism |
| title | VEGF-A Inhibition as a Potential Therapeutic Approach in Merkel Cell Carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T12%3A06%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=VEGF-A%20Inhibition%20as%20a%20Potential%20Therapeutic%20Approach%20in%20Merkel%20Cell%20Carcinoma&rft.jtitle=Journal%20of%20investigative%20dermatology&rft.au=Kervarrec,%20Thibault&rft.date=2019-03-01&rft.volume=139&rft.issue=3&rft.spage=736&rft.epage=739&rft.pages=736-739&rft.issn=0022-202X&rft.eissn=1523-1747&rft_id=info:doi/10.1016/j.jid.2018.08.029&rft_dat=%3Cproquest_hal_p%3E2126904708%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2126904708&rft_id=info:pmid/30359576&rft_els_id=S0022202X18326824&rfr_iscdi=true |